Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01506700 · ClinicalTrials.gov registry record
Real Time Optical Coherence Tomography (OCT) of Human Tissue
A clinical trial, sponsored by Diagnostic Photonics.
- Terminated
- Registry status
- 5
- Enrollment target
NCT01506700: Clinical Trial study, sponsored by Diagnostic Photonics.
NCT01506700 is a clinical trial that was terminated before completion, run by Diagnostic Photonics. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01506700 was terminated before completion, sponsored by Diagnostic Photonics.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This is a single-arm, prospective, study of an optical imaging device on approximately twenty (20) subjects undergoing lumpectomies at one study site. In vivo and ex vivo imaging will be performed on study subjects with results being compared to final pathology.
Interventions
- DEVICE Optical Coherence Tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-05 |
| Est. Completion | 2019-07-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01506700
The ClinicalTrials.gov registry entry for NCT01506700 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Diagnostic Photonics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Optical Coherence Tomography is the first listed.
NCT01506700 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01506700 about?
NCT01506700 is a clinical study titled "Real Time Optical Coherence Tomography (OCT) of Human Tissue". This is a single-arm, prospective, study of an optical imaging device on approximately twenty (20) subjects undergoing lumpectomies at one study site. In vivo and ex vivo imaging will be performed on study subjects with results being compared to final pathology.
What is the current status of trial NCT01506700?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2012-05. Estimated completion is 2019-07-17.
What interventions are being tested in trial NCT01506700?
The interventions under investigation include: Optical Coherence Tomography (DEVICE).
Who is sponsoring clinical trial NCT01506700?
This trial is sponsored by Diagnostic Photonics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.